DOI:
10.1055/s-00043364
Pharmaceutical Fronts
LinksClose Window
References
Pellicciari R, Pruzanski M, Gioiello A.
The discovery of obeticholic acid (Ocaliva™): first-in-class FXR agonist.
In: Fischer J, Klein C, Childers WE.
Successful Drug Discovery.
3rd ed..
Weinheim: Wiley-VCH; 2018: 197-244
Access:
We do not assume any responsibility for the contents of the web pages of other providers.